Literature DB >> 17522219

The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells.

Karen Y Twu1, Rei-Lin Kuo, Jesper Marklund, Robert M Krug.   

Abstract

The NS1A proteins of human influenza A viruses bind CPSF30, a cellular factor required for the processing of cellular pre-mRNAs, thereby inhibiting the production of all cellular mRNAs, including beta interferon mRNA. Here we show that the NS1A protein of the pathogenic H5N1 influenza A/Hong Kong/483/97 (HK97) virus isolated from humans has an intrinsic defect in CPSF30 binding. It does not bind CPSF30 in vitro and causes high beta interferon mRNA production and reduced virus replication in MDCK cells when expressed in a recombinant virus in which the other viral proteins are encoded by influenza A/Udorn/72. We traced this defect to the identities of amino acids 103 and 106 in the HK97 NS1A protein, which differ from the consensus amino acids, F and M, respectively, found in the NS1A proteins of almost all human influenza A virus strains. X-ray crystallography has shown that F103 and M106, which are not part of the CPSF30 binding pocket of the NS1A protein, stabilize the NS1A-CPSF30 complex. In contrast to the HK97 NS1A protein, the NS1A proteins of H5N1 viruses isolated from humans after 1998 contain F103 and M106 and hence bind CPSF30 in vitro and do not attenuate virus replication. The HK97 NS1A protein is less attenuating when expressed in a virus that also encodes the other internal HK97 proteins and under these conditions binds to CPSF30 to a substantial extent in vivo. Consequently, these internal HK97 proteins largely compensate for the absence of F103 and M106, presumably by stabilizing the NS1A-CPSF30 complex.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17522219      PMCID: PMC1951328          DOI: 10.1128/JVI.00006-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  The influenza virus NS1 protein forms multimers in vitro and in vivo.

Authors:  M E Nemeroff; X Y Qian; R M Krug
Journal:  Virology       Date:  1995-10-01       Impact factor: 3.616

2.  Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor.

Authors:  Y Lu; M Wambach; M G Katze; R M Krug
Journal:  Virology       Date:  1995-12-01       Impact factor: 3.616

3.  Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness.

Authors:  K Subbarao; A Klimov; J Katz; H Regnery; W Lim; H Hall; M Perdue; D Swayne; C Bender; J Huang; M Hemphill; T Rowe; M Shaw; X Xu; K Fukuda; N Cox
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

4.  A pandemic warning?

Authors:  J C de Jong; E C Claas; A D Osterhaus; R G Webster; W L Lim
Journal:  Nature       Date:  1997-10-09       Impact factor: 49.962

5.  RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids.

Authors:  W Wang; K Riedel; P Lynch; C Y Chien; G T Montelione; R M Krug
Journal:  RNA       Date:  1999-02       Impact factor: 4.942

6.  Influenza virus inhibits cleavage of the HSP70 pre-mRNAs at the polyadenylation site.

Authors:  K Shimizu; A Iguchi; R Gomyou; Y Ono
Journal:  Virology       Date:  1999-02-15       Impact factor: 3.616

7.  Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong.

Authors:  D L Suarez; M L Perdue; N Cox; T Rowe; C Bender; J Huang; D E Swayne
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

8.  PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice.

Authors:  Kyoko Shinya; Stefan Hamm; Masato Hatta; Hiroshi Ito; Toshihiro Ito; Yoshihiro Kawaoka
Journal:  Virology       Date:  2004-03-15       Impact factor: 3.616

9.  Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs.

Authors:  M E Nemeroff; S M Barabino; Y Li; W Keller; R M Krug
Journal:  Mol Cell       Date:  1998-06       Impact factor: 17.970

10.  Avian influenza A (H5N1) in 10 patients in Vietnam.

Authors:  Tinh Hien Tran; Thanh Liem Nguyen; Thi Dung Nguyen; Thi San Luong; Phuong Mai Pham; van Vinh Chau Nguyen; Thi Suu Pham; Cong Dong Vo; Thi Quynh Mai Le; Thi Thi Ngo; Bach Khoa Dao; Phuc Phat Le; Thanh Truong Nguyen; Thuy Long Hoang; Viet Tung Cao; Truong Giang Le; Dac Tho Nguyen; Hong Nga Le; Kim Tien Nguyen; Hoang San Le; Van Tuan Le; Dolecek Christiane; Tan Thanh Tran; de Jong Menno; Constance Schultsz; Peter Cheng; Wilina Lim; Peter Horby; Jeremy Farrar
Journal:  N Engl J Med       Date:  2004-02-25       Impact factor: 91.245

View more
  79 in total

1.  Glycine 184 in nonstructural protein NS1 determines the virulence of influenza A virus strain PR8 without affecting the host interferon response.

Authors:  Sabine Steidle; Luis Martínez-Sobrido; Markus Mordstein; Stefan Lienenklaus; Adolfo García-Sastre; Peter Stäheli; Georg Kochs
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host response.

Authors:  Zhongfang Wang; Nicole C Robb; Eva Lenz; Thorsten Wolff; Ervin Fodor; Stephan Pleschka
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

3.  Structural Basis for a Novel Interaction between the NS1 Protein Derived from the 1918 Influenza Virus and RIG-I.

Authors:  Alexander S Jureka; Alex B Kleinpeter; Gabriel Cornilescu; Claudia C Cornilescu; Chad M Petit
Journal:  Structure       Date:  2015-09-10       Impact factor: 5.006

4.  Functional Evolution of Influenza Virus NS1 Protein in Currently Circulating Human 2009 Pandemic H1N1 Viruses.

Authors:  Amelia M Clark; Aitor Nogales; Luis Martinez-Sobrido; David J Topham; Marta L DeDiego
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

5.  Exploring naphthyl-carbohydrazides as inhibitors of influenza A viruses.

Authors:  Sanmitra Barman; Lei You; Ran Chen; Vlad Codrea; Grace Kago; Ramakrishna Edupuganti; Jon Robertus; Robert M Krug; Eric V Anslyn
Journal:  Eur J Med Chem       Date:  2013-11-07       Impact factor: 6.514

Review 6.  Pathogenicity of highly pathogenic avian influenza virus in mammals.

Authors:  Emmie de Wit; Yoshihiro Kawaoka; Menno D de Jong; Ron A M Fouchier
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

7.  Structural analyses reveal the mechanism of inhibition of influenza virus NS1 by two antiviral compounds.

Authors:  Alex B Kleinpeter; Alexander S Jureka; Sally M Falahat; Todd J Green; Chad M Petit
Journal:  J Biol Chem       Date:  2018-08-03       Impact factor: 5.157

8.  The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV.

Authors:  Wenjun Ma; Dominique Brenner; Zhongfang Wang; Bianca Dauber; Christina Ehrhardt; Katrin Högner; Susanne Herold; Stephan Ludwig; Thorsten Wolff; Kangzhen Yu; Jürgen A Richt; Oliver Planz; Stephan Pleschka
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

9.  Contribution of double-stranded RNA and CPSF30 binding domains of influenza virus NS1 to the inhibition of type I interferon production and activation of human dendritic cells.

Authors:  Irene Ramos; Elena Carnero; Dabeiba Bernal-Rubio; Christopher W Seibert; Liset Westera; Adolfo García-Sastre; Ana Fernandez-Sesma
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

10.  Early control of H5N1 influenza virus replication by the type I interferon response in mice.

Authors:  Kristy J Szretter; Shivaprakash Gangappa; Jessica A Belser; Hui Zeng; Hualan Chen; Yumiko Matsuoka; Suryaprakash Sambhara; David E Swayne; Terrence M Tumpey; Jacqueline M Katz
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.